Peptide Research Library

    Your comprehensive resource for peptide science. Explore compound monographs, methodology guides, published studies, and essential terminology.

    Rigorous Editorial Standards

    All content is authored by scientists with advanced degrees in biochemistry, pharmacology, and related fields, then independently reviewed for scientific accuracy. Every claim is supported by peer-reviewed citations.

    Recent Studies

    View all studies →
    2025
    foxo4-dri

    FOXO4-DRI regulates endothelial cell senescence via P53 signaling pathway

    Elucidated the mechanism by which FOXO4-DRI targets senescent endothelial cells through the p53 signaling pathway. Demonstrated that the peptide selectively triggers apoptosis in senescent but not proliferating endothelial cells, with implications for vascular aging research.

    2025
    foxo4-dri

    FOXO4-DRI induces apoptosis of senescent fibroblasts in keloid tissue

    Demonstrated that FOXO4-DRI selectively eliminates senescent fibroblasts in keloid scar tissue, reducing collagen overproduction and fibrotic remodeling. Provides evidence for senolytic therapy as a novel approach to pathological scarring.

    2024
    ara-290

    Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the beta-common receptor in mice with cerebral ischemic stroke

    Showed that ARA-290 exerts neuroprotective effects comparable to erythropoietin in a mouse middle cerebral artery occlusion model, without causing erythropoiesis. The protective mechanism operates through the beta-common receptor, reducing neuronal apoptosis and inflammatory cytokines.

    2024
    carnosine

    The protective role of carnosine against type 2 diabetes-induced cognitive impairment

    Reviewed carnosine's neuroprotective role in type 2 diabetes-induced cognitive decline. Carnosine's antioxidant, anti-inflammatory, and anti-glycation properties may slow neurodegenerative processes accelerated by diabetes. Proposed as an accessible, inexpensive therapeutic candidate for diabetic cognitive impairment.